Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Same active ingredient as Mounjaro & Zepbound
Tirzepatide, the key component in both Mounjaro and Zepbound, operates by targeting dual hormone receptorsGLP-1 and GIP
why or why not
8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al
Targeted mechanisms: Many are designed to influence a specific receptor, pathway, or biological signal
Case reports and observational commentary suggest monitoring may be reasonable in long-duration therapy, particularly when intake is reduced
